J Allergy Clin Immunol Pract 2025 Jan
Dupilumab Use in Patients With Hypereosinophilic Syndromes: A Multicenter Case Series and Review of the Literature.
Related Questions
Dupixent was started for asthma. Eosinophils rose from 880 to 1940 after 6-8 weeks of therapy.
New answer by at Mayo Clinic Rochester (January 23, 2026)
Transient eosinophilia been noted in patients being treated with dupilumab for asthma, chronic rhinosinusitis with nasal polyposis, and atopic dermatitis. In a review of 11 du...